To elucidate the possible mechanisms through which DCN inhibits IBC invasion and tumorigenesis, we used reverse-phase protein array proteomic profiling to compare control and DCN-overexpressing cells. The gene discussed is DCN; the disease is inflammatory breast carcinoma.